111 related articles for article (PubMed ID: 55502)
1. Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy.
Samuels ML; Johnson DE; Holoye PY; Lanzotti VJ
JAMA; 1976 Mar; 235(11):1117-20. PubMed ID: 55502
[TBL] [Abstract][Full Text] [Related]
2. Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.
Krikorian JG; Daniels JR; Brown BW; Hu MS
Cancer Treat Rep; 1978 Oct; 62(10):1455-63. PubMed ID: 81719
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer.
Kawai K; Akaza H
Expert Opin Drug Saf; 2003 Nov; 2(6):587-96. PubMed ID: 14585067
[TBL] [Abstract][Full Text] [Related]
4. Continuous intravenous bleomycin (NSC-125066) therapy with vinblastine (NSC-49842) in stage III testicular neoplasia.
Samuels ML; Johnson DE; Holoye PY
Cancer Chemother Rep; 1975; 59(3):563-70. PubMed ID: 54212
[TBL] [Abstract][Full Text] [Related]
5. Bleomycin-induced pneumonitis in three patients treated with chemotherapy for primary advanced seminoma.
Stein ME; Zidan J; Charas T; Gershuny A; Ben-Yosef R
J BUON; 2015; 20(3):928-32. PubMed ID: 26214649
[TBL] [Abstract][Full Text] [Related]
6. Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation.
Venkatramani R; Kamath S; Wong K; Olch AJ; Malvar J; Sposto R; Goodarzian F; Freyer DR; Keens TG; Mascarenhas L
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):942-8. PubMed ID: 23726005
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography of pulmonary bleomycin toxicity.
Mills P; Husband J
Semin Ultrasound CT MR; 1990 Oct; 11(5):417-22. PubMed ID: 1699571
[No Abstract] [Full Text] [Related]
8. Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of literature.
Higa GM; AlKhouri N; Auber ML
Pharmacotherapy; 1997; 17(6):1315-21. PubMed ID: 9399618
[TBL] [Abstract][Full Text] [Related]
9. Role of pulmonary function tests in the prevention of bleomycin pulmonary toxicity during chemotherapy for metastatic testicular teratoma.
Lucraft HH; Wilkinson PM; Stretton TB; Read G
Eur J Cancer Clin Oncol; 1982 Feb; 18(2):133-9. PubMed ID: 6178590
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for bleomycin-induced pneumonitis.
Van Barneveld PW; van der Mark TW; Sleijfer DT; Mulder NH; Koops HS; Sluiter HJ; Peset R
Am Rev Respir Dis; 1984 Dec; 130(6):1078-81. PubMed ID: 6210002
[TBL] [Abstract][Full Text] [Related]
11. Delayed onset bleomycin-induced pneumonitis.
Uzel I; Ozguroglu M; Uzel B; Kaynak K; Demirhan O; Akman C; Oz F; Yaman M
Urology; 2005 Jul; 66(1):195. PubMed ID: 15992893
[TBL] [Abstract][Full Text] [Related]
12. Low toxicity with continuous infusion of high-dose bleomycin in poor prognostic testicular cancer.
Gerson R; Tellez Bernal E; Lazaro Leon M; Sanchez Forgach E; Garcia Irigoyen C; Gutierrez Godinez F; Garcia Gonzalez H
Am J Clin Oncol; 1993 Aug; 16(4):323-6. PubMed ID: 7687091
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary toxicity induced by pepleomycin 3-[(S)-1'-phenylethylamino] propylamino-bleomycin.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Shibuya M; Shimabukuro Z; Koketsu H; Nakajima T; Niitani H
Jpn J Clin Oncol; 1983 Jun; 13(2):395-410. PubMed ID: 6193296
[TBL] [Abstract][Full Text] [Related]
14. Fatal pulmonary toxicity in testis cancer with bleomycin-containing chemotherapy.
Keijzer A; Kuenen B
J Clin Oncol; 2007 Aug; 25(23):3543-4. PubMed ID: 17687159
[No Abstract] [Full Text] [Related]
15. Natural course of bleomycin-induced pneumonitis. A follow-up study.
Van Barneveld PW; Sleijfer DT; van der Mark TW; Mulder NH; Koops HS; Sluiter HJ; Peset R
Am Rev Respir Dis; 1987 Jan; 135(1):48-51. PubMed ID: 2432813
[TBL] [Abstract][Full Text] [Related]
16. Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
Kawai K; Ando S; Hinotsu S; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Jul; 36(7):425-31. PubMed ID: 16790450
[TBL] [Abstract][Full Text] [Related]
17. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.
Comis RL; Kuppinger MS; Ginsberg SJ; Crooke ST; Gilbert R; Auchincloss JH; Prestayko AW
Cancer Res; 1979 Dec; 39(12):5076-80. PubMed ID: 91430
[TBL] [Abstract][Full Text] [Related]
18. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman.
Ahmed BM; Al-Zakwani IS
J Oncol Pharm Pract; 2013 Mar; 19(1):3-7. PubMed ID: 22504168
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for disseminated testicular cancer.
Einhorn LH; Donohue JP
Urol Clin North Am; 1977 Oct; 4(3):407-26. PubMed ID: 76358
[TBL] [Abstract][Full Text] [Related]
20. Severe bleomycin-induced pneumonitis. Clinical features and response to corticosteroids.
White DA; Stover DE
Chest; 1984 Nov; 86(5):723-8. PubMed ID: 6207992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
